| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ba782d3b1fd168eab19dd7b0875942aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_914af0075b01cf903262a8860682cb42 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495 |
| filingDate |
2004-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00776c4e811e650f8951093ded421aa0 |
| publicationDate |
2004-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2004110450-A1 |
| titleOfInvention |
Composition comprising a pulmonary surfactant and a pde5 inhibitor for the treatment of lung diseases |
| abstract |
The invention relates to the combined administration of a pulmonary surfactant and a PDE5 inhibitor for the treatment of a disease in which pulmonary surfactant malfunction and/or phosphodiesterase 5 (PDE5) activity is detrimental. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8853195-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2006217261-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2006217261-B8
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007097502-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006128675-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008532973-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010013925-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010013925-A2 |
| priorityDate |
2003-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |